This inventor holds 1 USPTO granted patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Eti Ishai
Introduction
Eti Ishai is a notable inventor based in Netanya, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of atorvastatin derivatives. His work has implications for the treatment of cholesterol-related conditions, showcasing the importance of innovation in healthcare.
Latest Patents
Eti Ishai holds a patent for the hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide. This invention provides a process for preparing atorvastatin hemi-calcium from an atorvastatin ester derivative using calcium hydroxide. The process can be conveniently integrated into a method for preparing atorvastatin hemi-calcium from an acetonide protected, ester protected β,δ-dihydroxy heptanoic acid precursor compound through a first acid hydrolysis step followed by base hydrolysis with calcium hydroxide. Notably, this latter process can be performed as a one-pot process, enhancing efficiency in pharmaceutical manufacturing.
Career Highlights
Eti Ishai is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on innovative solutions that address critical health issues. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in drug development.
Collaborations
Eti has collaborated with talented professionals such as Valerie Niddam and Ramy Lidor-Hadas. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.
Conclusion
Eti Ishai's contributions to the field of pharmaceuticals exemplify the vital role of innovation in healthcare. His patent for atorvastatin derivatives demonstrates his commitment to improving treatment options for patients. Through his work at Teva Pharmaceutical Industries Limited, he continues to make strides in the industry, showcasing the importance of collaboration and creativity in driving advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile